Article Details

Roche multiple sclerosis subcutaneous injection: late-breaking data - MarketScreener

Retrieved on: 2023-10-11 22:36:04

Tags for this article:

Click the tags to see associated articles and topics

Roche multiple sclerosis subcutaneous injection: late-breaking data - MarketScreener. View article details on HISWAI: https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Roche-multiple-sclerosis-subcutaneous-injection-late-breaking-data-45042337/

Excerpt

Late-breaking data from Roche's Phase III OCARINA II study have revealed that OCREVUS® subcutaneous injection was comparable to IV infusion in ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up